Depressão e ansiedade em população com quadros reumatológicos
Jaoude, Thaísa de Carvalho
MetadataMostrar registro completo
Rheumatic diseases have been defined as those relating to musculoskeletal and connective tissues. Through the analysis of the literature it is observed a significant prevalence among patients with these pathologies, and both depression and anxiety. The present study investigated, in two different studies, the relations between rheumatic diseases and mental disorders. The Study 1 presents a literature reviews organized in the form of article. The manuscript presents the product of a literature review in brazilian and foreign databases, in the last 25 years, examining the results on the prevalence of mental disorders in rheumatic diagnoses patients, particularly anxiety and depression. The review was organized to systematize the principal addressed rheumatologic diseases, the countries where the investigations were implemented, the populations investigated in these studies, and the prevalence observed between depression and anxiety in each case. In Study 2 indicators of depression and anxiety in users of rheumatology ambulatory are described, in a health and teaching unit, with exclusive service to users of the Social Health System. It was evaluated 85 patients, 76 women and 9 men, aged between 41 and 70 years. In the evaluation, the following instruments were used: 1) The questionnaire for survey of general information; 2) Beck Depression Inventory (BDI); 3) Beck Anxiety Inventory (BAI); 4) Inventory of Stress Symptoms of Lipp (ISSL); and; 5) Brazilian Economic Criteria of the ABEP. The results showed that 51.8% of the sample had a education equal or less to complete primary, and 31.8% are retired or removed by social security provision. In addition, 68.2% of them were identified as inserted into economic classes with power consumption equal or less than to Class C1; 37,6% of users had two or more diagnosis of rheumatic diseases. Indicators showed that 43.5% of users were under medical treatment with at least one psychotropic substance, with treatment duration ranging from 2 to 21 years. Users under psychotropic drug prescription had significantly higher scores of depression (Mann-Whitney: z = 6.513, p <0.000), anxiety (Mann- Whitney: z = 6.083, p <0.000) and stress (Mann-Whitney: z = 6.119; p <0.000). The rheumatics diseases most frequently found in the population were Fibromyalgia (n = 33), Osteoarthritis (n = 33) and Rheumatoid arthritis (n = 24). In the general population, there was a prevalence of 43.5% of depression, 57% anxiety and 31.4% of stress. Considering the prevalence of depression in the Fibromyalgia, Osteoarthritis and Rheumatoid Arthritis were observed respectively values of 87.9%, 60.6% and 37.5%. Anxiety showed a prevalence of 72.7% in Fibromyalgia, 36.4% in Osteoarthritis, and 29.2% in Rheumatoid Arthritis. It was discussed the importance of evaluation and multidisciplinary intervention, in particular the psychologist role, for the care of rheumatic diseases.